Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2

Conditions

Myelodysplastic Syndromes 244Leukemia, Myeloid, Acute 191Leukemia 145Leukemia, Myelogenous, Chronic, BCR-ABL Positive 139Precursor Cell Lymphoblastic Leukemia-Lymphoma 120Myeloproliferative Disorders 89Multiple Myeloma 84Leukemia, Lymphocytic, Chronic, B-Cell 78Lymphoma, Non-Hodgkin 76Primary Myelofibrosis 72Leukemia, Myelomonocytic, Chronic 69Lymphoma 67Hodgkin Disease 66Leukemia, Myeloid, Chronic-Phase 55Lymphoma, Mantle-Cell 50Blast Crisis 49Lymphoma, Large B-Cell, Diffuse 47Lymphoma, Follicular 44Leukemia, Myeloid, Accelerated Phase 44Congenital Abnormalities 41Lymphoma, B-Cell, Marginal Zone 40Burkitt Lymphoma 40Neoplasms, Plasma Cell 38Lymphoma, Large-Cell, Immunoblastic 35Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 35Polycythemia Vera 32Hematologic Neoplasms 31Myelodysplastic-Myeloproliferative Diseases 30Lymphoma, T-Cell, Cutaneous 29Anemia, Refractory, with Excess of Blasts 29

Interventions

Cyclophosphamide 2thymoglobulin 1plerixafor 1fludarabine phosphate 1fludarabine 1aldesleukin 1Thiotepa 1Tacrolimus 1Rituximab 1Mycophenolic Acid 1Melphalan 1Interleukin-2 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cytarabine 1Clofarabine 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Sarcoma, Myeloid × Myeloid × Clear all
NCT02259348 2017-05-30

Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation

St. Jude Children's Research Hospital

Phase 2 Terminated
12 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT01621477 2017-02-20

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

St. Jude Children's Research Hospital

Phase 2 Terminated
34 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡